Skip to main content
Clinical Trials/EUCTR2006-002528-41-NL
EUCTR2006-002528-41-NL
Active, not recruiting
Not Applicable

A comparison of the clinical efficacies of Fusidic acid hydrophilic cream 20 mg/g and Fucidin in the treatment of adult and paediatric patients with impetigo - FUSIDIC ACID CREAM STUDY

Interdos Pharma bv0 sites170 target enrollmentMay 17, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Interdos Pharma bv
Enrollment
170
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 17, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Interdos Pharma bv

Eligibility Criteria

Inclusion Criteria

  • \- Subjects having a clinical diagnosis of localised impetigo contagiosa (not the extensive forms)
  • \- Subject age: more than 18 months
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • \- Subjects whose temperature \>38\.5 degrees C
  • \- Subjects who have extensive forms of impetigo, or other infections of deeper skin structure, that require systemic treatment
  • \- Subjects with secondary impetigo, where the infection is secondary to some other underlying skin disease, such as scabies or eczema
  • \- Subjects with sunburn and those who may have considerable exposure to sunlight, including UV lamps, during the study period
  • \- Subjects who have a history of hypersensitivity to fusidic acid or any of the components of the study medication
  • \- Other disease: subjects with a recent history (within 3 months prior to enrolment) of severe systemic disease.
  • \- Other medication:
  • 1\) For 24 hours prior to entry, subjects should not have been treated with topical steroids, topical retinoids, or topical antibiotics
  • 2\) For 1 week prior to entry, subjects should not have utilised medicated shampoos or medicated cleansers of any type. Non\-medicated cleansers and emollients are permitted at the discretion of the investigator.
  • 3\) For 1 month prior to entry, subjects should not have been treated with UV\-lamp irradiation, systemic antibiotics, or parenteral corticosteroids.

Outcomes

Primary Outcomes

Not specified

Similar Trials